Frontiers in Immunology
Case Report: Unplanned pregnancy during treatment with inebilizumab in patients with AQP4-IgG-seropositive NMOSD: report of two cases
By Wenqin Luo, Fenglin Shi, Xu Zhu and 2 others.
Abstract
Neuromyelitis optica spectrum disorder (NMOSD) predominantly affects women and has a median age at onset of 40 years, meaning that many patients are of childbearing age. However, management of pregnant women with NMOSD remains extremely challenging. We report two patients with NMOSD who had unplanned pregnancies during inebilizumab (INE) treatment and successful deliveries. These cases provide preliminary clinical information regarding maternal disease control and pregnancy outcomes following INE exposure.
Keywords
- Multiple Sclerosis Research Studies
- Neuromyelitis optica
- Pregnancy
- Spectrum disorder
- Disease
- Gestation
- Open access
Source
Published in Frontiers in Immunology. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
